Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04477577 · ClinicalTrials.gov registry record · NA
First Heroes: Engaging Fathers in the First 1000 Days
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 657
- Enrollment target
NCT04477577: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04477577 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 657 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04477577, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 657 participants
- Enrollment target
Study Summary
The First Heroes study plans to influence weight and health trajectories, modify disease risk, and improve health care services for mother-father-infant triads from racial/ethnic minority and health disparity populations. This study is a two-arm, randomized controlled trial recruiting from Massachusetts General Hospital (MGH) obstetrics practices. This study will enroll 250 father-mother dyads in the second trimester of pregnancy and intervene through their offspring's 1-year birthday. Each mother-father dyad participating will be randomly assigned to one of two arms: 1. Obstetric and Pediatric Standard of Care + New Parent Engagement Intervention Arm or; 2. Obstetric and Pediatric Standard of Care + Safety Control Arm.
Interventions
- BEHAVIORAL Safety Control
- BEHAVIORAL New Parent Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 657 participants |
| Start Date | 2020-08-04 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04477577
The ClinicalTrials.gov registry entry for NCT04477577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 657 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Safety Control is the first listed.
NCT04477577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04477577 about?
NCT04477577 is a clinical study titled "First Heroes: Engaging Fathers in the First 1000 Days". The First Heroes study plans to influence weight and health trajectories, modify disease risk, and improve health care services for mother-father-infant triads from racial/ethnic minority and health disparity populations. This study is a two-arm, randomized controlled trial recruiting from Massachu...
What is the current status of trial NCT04477577?
This trial is currently completed. It is a NA study. The enrollment target is 657 participants. The study started on 2020-08-04. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT04477577?
The interventions under investigation include: Safety Control (BEHAVIORAL), New Parent Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04477577?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.